The store will not work correctly when cookies are disabled.
3-(2-chlorophenylcarbamoyl)-1-methyl-1H-pyrazole-5-carboxylic acid
ID: ALA4878930
PubChem CID: 19580056
Max Phase: Preclinical
Molecular Formula: C12H10ClN3O3
Molecular Weight: 279.68
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cn1nc(C(=O)Nc2ccccc2Cl)cc1C(=O)O
Standard InChI: InChI=1S/C12H10ClN3O3/c1-16-10(12(18)19)6-9(15-16)11(17)14-8-5-3-2-4-7(8)13/h2-6H,1H3,(H,14,17)(H,18,19)
Standard InChI Key: TWVGGGWFDGMLEB-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
31.0736 -15.7458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0724 -16.5732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7873 -16.9861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5037 -16.5727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5008 -15.7422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7855 -15.3330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7871 -17.8111 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
30.3577 -16.9851 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.6435 -16.5721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9287 -16.9840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6441 -15.7471 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.1787 -16.6501 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.6262 -17.2628 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.0382 -17.9777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8452 -17.8066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8058 -17.1759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7021 -18.7311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8815 -18.8167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.1865 -19.3988 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
3 7 1 0
2 8 1 0
8 9 1 0
9 10 1 0
9 11 2 0
10 12 2 0
12 13 1 0
13 14 1 0
14 15 2 0
15 10 1 0
13 16 1 0
14 17 1 0
17 18 1 0
17 19 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 279.68 | Molecular Weight (Monoisotopic): 279.0411 | AlogP: 2.02 | #Rotatable Bonds: 3 |
Polar Surface Area: 84.22 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.25 | CX Basic pKa: ┄ | CX LogP: 2.06 | CX LogD: -1.38 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.90 | Np Likeness Score: -2.07 |
References
1. Richardson NL, O'Malley LJ, Weissberger D, Tumber A, Schofield CJ, Griffith R, Jones NM, Hunter L.. (2021) Discovery of neuroprotective agents that inhibit human prolyl hydroxylase PHD2., 38 [PMID:33862469] [10.1016/j.bmc.2021.116115] |